Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susan L Samson

Showing results (1-10 of 68) with videos related to

Pageof 7
Sort By:
Drugs|July 31, 2016
Management of Hyperglycemia in Patients With Acromegaly Treated With Pasireotide LARSusan L Samson
Pituitary|August 1, 2024
Is diabetes with acromegaly for life?Susan L Samson
Best Practice & Research. Clinical Endocrinology & Metabolism|March 28, 2026
Resistant prolactinomasSusan L Samson
Neuroendocrinology|March 21, 2015
Pasireotide in Acromegaly: An Overview of Current Mechanistic and Clinical DataSusan L Samson
Current Opinion in Endocrinology, Diabetes, and Obesity|February 14, 2013
GLP-1R agonist therapy for diabetes: benefits and potential risksSusan L Samson, Alan Garber
Journal of Diabetes and Its Complications|January 29, 2013
Potential of incretin-based therapies for non-alcoholic fatty liver diseaseSusan L Samson, Mandeep Bajaj
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|May 31, 2021
Dedication to Alan J. Garber, MD, PhD, MACE: February 27, 1943-April 9, 2020Susan L Samson, Vin Tangpricha
Metabolic Syndrome and Related Disorders|May 21, 2014
Cardiovascular effects of incretin therapy in diabetes careJongoh Kim, Susan L Samson
Trends in Endocrinology and Metabolism: TEM|March 1, 2006
Gene therapy for diabetes: reinventing the isletSusan L Samson, Lawrence Chan
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|June 28, 2014
AACE/ACE Disease State Clinical Review: Dopamine Agonists for Hyperprolactinemia and the Risk of Cardiac Valve DiseaseSusan L Samson, Shereen Ezzat
Pageof 7

Showing results (1-10 of 68) with videos related to

Sort By:
Pageof 7
Drugs|July 31, 2016
Management of Hyperglycemia in Patients With Acromegaly Treated With Pasireotide LARSusan L Samson
Pituitary|August 1, 2024
Is diabetes with acromegaly for life?Susan L Samson
Best Practice & Research. Clinical Endocrinology & Metabolism|March 28, 2026
Resistant prolactinomasSusan L Samson
Neuroendocrinology|March 21, 2015
Pasireotide in Acromegaly: An Overview of Current Mechanistic and Clinical DataSusan L Samson
Current Opinion in Endocrinology, Diabetes, and Obesity|February 14, 2013
GLP-1R agonist therapy for diabetes: benefits and potential risksSusan L Samson, Alan Garber
Journal of Diabetes and Its Complications|January 29, 2013
Potential of incretin-based therapies for non-alcoholic fatty liver diseaseSusan L Samson, Mandeep Bajaj
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|May 31, 2021
Dedication to Alan J. Garber, MD, PhD, MACE: February 27, 1943-April 9, 2020Susan L Samson, Vin Tangpricha
Metabolic Syndrome and Related Disorders|May 21, 2014
Cardiovascular effects of incretin therapy in diabetes careJongoh Kim, Susan L Samson
Trends in Endocrinology and Metabolism: TEM|March 1, 2006
Gene therapy for diabetes: reinventing the isletSusan L Samson, Lawrence Chan
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|June 28, 2014
AACE/ACE Disease State Clinical Review: Dopamine Agonists for Hyperprolactinemia and the Risk of Cardiac Valve DiseaseSusan L Samson, Shereen Ezzat
Pageof 7